Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147] (International Journal for Parasitology: Drugs and Drug Resistance (2021) 16 (140–147), (S221132072100021X), (10.1016/j.ijpddr.2021.05.002))

Philip T. LoVerde, Sevan N. Alwan, Alexander B. Taylor, Jayce Rhodes, Frédéric D. Chevalier, Timothy JC Anderson, Stanton F. McHardy

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that the acknowledgements of SNA were funded by SABER IRACDA program 2k12GM111726 was inadvertently left out of the article.

Original languageEnglish (US)
Pages (from-to)103
Number of pages1
JournalInternational Journal for Parasitology: Drugs and Drug Resistance
Volume18
DOIs
StatePublished - Apr 2022

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147] (International Journal for Parasitology: Drugs and Drug Resistance (2021) 16 (140–147), (S221132072100021X), (10.1016/j.ijpddr.2021.05.002))'. Together they form a unique fingerprint.

Cite this